Science

Gerry Hanna: Routine Scanning/surveillance for Cancer Metastases is not Beneficial and Maybe Harmful in Some Cases

Gerry Hanna/X

May 1, 2025, 10:14

Gerry Hanna: Routine Scanning/surveillance for Cancer Metastases is not Beneficial and Maybe Harmful in Some Cases

Gerry Hanna, Marie Curie Chair of Clinical Oncology at Trinity College Dublin, shared on X:

“Routine Surveillance for Cancer Metastases — Does It Help or Harm Patients?”

This short paper in today’s NEJM suggests that routine scanning/surveillance is not beneficial and maybe harmful in some cases. Food for thought…”

Routine Surveillance for Cancer Metastases — Does It Help or Harm Patients?

Authors: H. Gilbert Welch and Lesly A. Dossett

You can Read the Full Article on The New England Journal of Medicine.

Gerry Hanna: Routine Scanning/surveillance for Cancer Metastases is not Beneficial and Maybe Harmful in Some Cases

More posts featuring Gerry Hanna.

cancer cancer metastases clinical oncology fight against cancer Gerry Hanna Global fight against cancer H Gilbert Welch Lesly A. Dossett Marie Curie Chair NEJM OncoDaily Oncology patients The New England Journal of Medicine. Trinity College Dublin

Oliver Bogler Announced the Launch of the NanCI AI Webapp for Scientific Literature and Networking

Joe Biden Diagnosed with Aggressive Metastatic Prostate Cancer at Age 82

DESTINY-Breast06 Trial Updates at ESMO Breast 2025 Confirms T-DXd Efficacy in HER2-Low and Ultralow Metastatic Breast Cancer

FDA Approves Belzutifan (Welireg) for Advanced Pheochromocytoma and Paraganglioma: Results of LITESPARK-015 Trial

New World Cancer Declaration 2025–2035 by UICC